Blood ApS: Financial statements 2023
CVR: 37650978
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Blood ApS (CVR 37650978) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -8,618 and a net result of DKK -6,361 compared with DKK -3,623 the year before. Equity in the 2023 report amounted to DKK 53,859. The solvency ratio was 93.9%.
- Gross Profit
- DKK -8,618
- Profit/Loss
- DKK -6,361
- Equity
- DKK 53,859
- Total Assets
- DKK 57,334
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -9 t. | -6 t. | 54 t. | 0 |
| 2022 | - | -4 t. | -4 t. | 130 t. | 0 |
| 2021 | - | -2 t. | 246 t. | 248 t. | 0 |
| 2020 | - | -2 t. | 62 t. | 115 t. | 0 |
| 2019 | - | -3 t. | 300 t. | 163 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Blood ApS has published its annual report for 2022. Gross profit came to DKK -3,900, and the net result was DKK -3,623.
About Blood ApS
Blood ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mikkel Nissen Jersin. The company is owned by Mikkel Nissen Jersin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,778 and a net result of DKK 142,452 compared with DKK -7,047 the year before. Equity in the 2025 report amounted to DKK 69,264.